Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial
Matthew Fish, Jennifer Rynne, A.R. Jennings, C Lam, Abigail Lamikanra, Jeremy Ratcliff, S. Cellone-Trevelin, Emma Timms, J. Jiriha, Isabella Tosi, R. Pramanik, Peter Simmonds, Sohan Seth, James H. Williams, Anthony Gordon, Julian C. Knight, Debra Smith, Justin P. Whalley, David A Harrison, Kathy Rowan, Heli Harvala, Paul Klenerman, Lise J Estcourt, David K. Menon, David J. Roberts, Manu Shankar‐Hari, the REMAP-CAP Immunoglobulin Domain UK Investigators
Topics & Concepts
MedicineRandomized controlled trialClinical endpointBiomarkerInternal medicineClinical trialPneumoniaConvalescent plasmaDiseaseCoronavirus disease 2019 (COVID-19)Intensive care medicineImmunologyBiologyInfectious disease (medical specialty)BiochemistrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19